Rate of Postpyloric Migration of Spiral Nasojejunal Tubes in Brain Injured Patients

This study has been completed.

Sponsor:

Information provided by:

Capital Medical University

ClinicalTrials.gov Identifier:

NCT00562146

First received: November 20, 2007

Last updated: October 27, 2008

Last verified: October 2008

History of Changes

Purpose

The success rate of unguided nasojejunal feeding tube insertion will be determined in acute brain injured patients. Factors influencing tube self-progression will be evaluated.

Condition	Intervention
Acute Brain Injury	Procedure: placement of spiral nasojejunal tube


Study Type:	Observational
Study Design:	Observational Model: Case Control Time Perspective: Prospective
Official Title:	Rate of Postpyloric Migration of Spiral Nasojejunal Tubes in Brain Injured Patients

Further study details as provided by Capital Medical University:


Enrollment:	120
Study Start Date:	December 2007
Study Completion Date:	September 2008
Primary Completion Date:	September 2008 (Final data collection date for primary outcome measure)

Groups/Cohorts	Assigned Interventions
1 Successful progression of spiral tube to duodenum within 3 days	Procedure: placement of spiral nasojejunal tube spiral nasojejunal tube will be placed after enrollment of the patients
2 Failure of progression to duodenum within 3 days	Procedure: placement of spiral nasojejunal tube spiral nasojejunal tube will be placed after enrollment of the patients

Detailed Description:

Nutrition support is important in brain injured patients. Several studies have shown that small bowel feeding compared with gastric feeding may be associated with a reduction in pneumonia in critically ill patients. The Canadian Clinical Practice Guidelines recommended that small bowel feedings should be considered for patients at high risk for intolerance to enteral nutrition.

There are several methods to place postpyloric tube, but there is a high success rate with endoscopic or radiological assistance. However, they are time consuming procedures, which is of limited availability at bedside and requires trained staff.

Nasojejunal tube with spiral end (Flocare Bengmark NJ tube) has been used for bedside placement for 10 years. But only limited data are available for success rate, especially in brain injured patients. The aim of this study is to access the success rate and influencing factors of spiral end nasojejunal tube in such a population.

Eligibility


Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Probability Sample

Study Population

Acute brain injured patients admitted to Neuro-ICU will be consecutively enrolled.

Criteria

Inclusion Criteria:

Acute brain injured patients admitted to Neuro-ICU

Exclusion Criteria:

Patients' stay in ICU shorter than 3 days
Patients with contraindication to naso-feeding tube placement

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00562146

Locations


China, Beijing
ICU, Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing, China, 100050

Sponsors and Collaborators

Capital Medical University

Investigators


Study Chair:	Jian-Xin Zhou, MD	ICU, Beijing Tiantan Hospital, Capital Medical University

More Information

No publications provided


Responsible Party:	Jian-Xin Zhou, ICU, Beijing Tiantan Hospital, Capital Medical University
ClinicalTrials.gov Identifier:	NCT00562146 History of Changes
Other Study ID Numbers:	BJTTH-ICU-07-011, BJTTH-ICU-07-011
Study First Received:	November 20, 2007
Last Updated:	October 27, 2008
Health Authority:	China: Ministry of Health

Keywords provided by Capital Medical University:


nutrition enteral access

ClinicalTrials.gov processed this record on February 27, 2015

To Top